SuperworthSpruce Biosciences shares outstanding SPRB
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 2.4M
- On a year earlier
- +311.3%
- more shares
Spruce Biosciences had 2.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 311.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.3M | +134% |
| FY2024 | 553.2K | +2% |
| FY2023 | 543.5K | +73% |
| FY2022 | 314.1K | +0% |
| FY2021 | 312.7K | +2968% |
| FY2019 | 10.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.4M | +311% | |
| Q1 FY26 | 1.4M | +134% | |
| Q4 FY25 | 1.3M | +134% | |
| Q3 FY25 | 563.1K | +2% | |
| Q2 FY25 | 591.1K | +8% | |
| Q1 FY25 | 586.1K | +7% | |
| Q4 FY24 | 553.2K | +2% | |
| Q3 FY24 | 550.6K | +1% | |
| Q2 FY24 | 548.8K | +2% | |
| Q1 FY24 | 547.9K | +29% | |
| Q4 FY23 | 543.5K | +73% | |
| Q3 FY23 | 542.8K | +73% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Spruce Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.